21557 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a NS, NS, NS, N chelating group
Sub-classes:RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING
#2DLL3-SPECIFIC BINDING CONSTRUCTS AND THEIR USE IN RADIOTHERAPY
#3MULTIVALENT GLYCO-COMPLEX, IMAGING AGENT AND USES THEREOF
#4THERAPEUTIC AND IMAGING AGENTS FOR TARGETING MYOCARDIAL TISSUE
#5COMPOSITIONS AND METHODS FOR TARGETED PARTICLE PENETRATION, DISTRIBUTION, AND RESPONSE IN MALIGNANT BRAIN TUMORS
#6RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING
#7METHOD OF USING ADENOSINE AND DIPYRIDAMOLE FOR PHARMACOLOGIC STRESS TESTING, WITH SPECIFIC COMPOSITIONS, UNIT DOSAGE FORMS AND KITS
#8Systems, Devices, and Methods for Gamma Entrainment using Sensory Stimuli to Alleviate Cognitive Deficits and/or Neuroinflammation Induced by Chemotherapy Agents
#9METAL NUCLIDE-LOADED CARBON MICROSPHERE (CMS), PREPARATION METHOD, AND USE THEREOF
#10SELECTIVE GIP RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING AND THERAPY PURPOSES
#11IMMUNOPET AND IMMUNOSPECT IMAGING TO IDENTIFY CYTOTOXIC T CELL ACTIVITY
#12Imaging and treatment of pathophysiologic conditions by Cerenkov radiation
#13Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
#14Inert nanocapsules
#15SYSTEM AND METHOD FOR OPTIMIZING RADIOTHERAPHY TREATMENTS
#16PEPTIDE PET/SPECT PROBES SPECIFIC TO ONCOPROTEINS IN TUMOR EXTRACELLULAR MATRIX
#17Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer
#18Fluorescent probe for cyclooxygenase-2
#19COMPOSITIONS AND METHODS FOR TARGETED PARTICLE PENETRATION, DISTRIBUTION, AND RESPONSE IN MALIGNANT BRAIN TUMORS
#20IMAGING METHOD OF AMPA RECEPTORS IN BRAIN OF PRIMATE ORGANISM, PROGRAM, DIAGNOSTIC AGENT, COMPANION DIAGNOSTIC AGENT, DRUG, SCREENING METHOD, INPUT TERMINAL, SERVER AND SYSTEM
#21RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING
#22Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer
#23Multifunctional chelators, complexes, and compositions thereof, and methods of using same
#24Radioactive compound for diagnosis of malignant melanoma and use thereof
#25Targeted Macrocyclic Agents for Dual Modality PET and MRI Imaging of Cancer
#26NON-IODINATED RADIOLABELED RADIOPAQUE MICROBEADS WITH MRI CONTRAST FOR RADIOEMBOLIZATION
#27System and method for quantitatively mapping mitochondrial membrane potential
#28Radiolabeled drug
#29Isotope preparation method
#30Imaging of glycogen synthase kinase 3
#31Systems and methods for minimally-invasive assessment of toxicity-induced tissue injury
#32Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
#33CANCER IMAGING AGENT
#34Quinoline-3-carboxamide compounds and their use in diagnosis
#35Radiopharmaceutical conjugate of a metabolite and an EPR agent, for targeting tumour cells
#36CARBOHYDRATE FUNCTIONALIZED CATANIONIC SURFACTANT VESICLES FOR DRUG DELIVERY
#37Cage-like bifunctional chelators, copper-64 radiopharmaceuticals and PET imaging using the same
#38Imaging and treatment of pathophysiologic conditions by Cerenkov radiation
#39Multifunctional chelators, complexes, and compositions thereof, and methods of using same
#40Tetrahydroxamate chelators of zirconium89 and niobium90 for use in diagnostic applications
#41Precursor for labeling therapeutic agent for liver cancer and method for manufacturing the same
#42RADIO-PHARMACEUTICAL COMPLEXES
#43Radio-pharmaceutical complexes
#44Double-labeled probe for molecular imaging and use thereof
#45METHOD OF USING ADENOSINE AND DIPYRIDAMOLE FOR PHARMACOLOGIC STRESS TESTING, WITH SPECIFIC COMPOSITIONS, UNIT DOSAGE FORMS AND KITS
#46Radiotracer precursor for imaging of hypoxic tissue, radiotracer, and method for preparing the same
#47Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
#48Compositions and methods for tumor imaging and targeting by a class of organic heptamethine cyanine dyes that possess dual nuclear and near-infrared properties
#49Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
#50In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
#51Tc imaging agents and methods of use
#52ARSENIC COMPLEXES FOR POTENTIAL DIAGNOSTIC APPLICATIONS
#53Radioimaging methods using teboroxime and thallium
#54COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET
#5599mTc IMAGING AGENTS AND METHODS OF USE
#5699mTc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical
#57Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies
#58Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies
#59In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
#60Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
#61Compositions and methods for delivering a substance to a biological target
#62Diagnostic method for atherosclerosis
#63CARBOHYDRATE FUNCTIONALIZED CATANIONIC SURFACTANT VESICLES FOR DRUG DELIVERY
#64Cage-like bifunctional chelators, copper-64 radiopharmaceuticals and PET imaging using the same
#65Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
#66Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA
#67Radioimaging applications of and novel formulations of teboroxime
#68METHODS AND COMPOSITIONS USING CHELATOR-ANTIBODY CONJUGATES
#69Tc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical
#70Inhibitors of carbonic anhydrase IX
#71Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates
#72Chelating Conjugates Having a Substituted Aromatic Moiety and Derivatives Thereof
#73Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies
#74Metal chelates having a perfluorinated PEG radical, processes for their preparation, and their use
#75Methods and devices for detection and therapy of atheromatous plaque
#76Compositions and methods for cellular imaging and therapy
#77Method of preparing rhenium-tricarbonyl complex and its precursor
#78Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
#79Charge neutral complexes of paramagnetic metals as intracellular magnetic resonance imaging contrast agents
#80Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions
#81Formulation of Tc and Re carbonyl complexes using stannous ion as the reductant for pertechnetate and perrhenate
#82Diagnostic method for atherosclerosis